IMAGING BIOMARKERS IN MULTIPLE SCLEROSIS
Pain, depression, slurred speech and feeling of numbness, tingling, or weakness. These are just some symptoms of Multiple Sclerosis (MS) disease, a long-term condition that…
QUIBIM’s AI-FUELED CHEST X-RAY CLASSIFIER GETS CE MARK
Chest X-ray classifier is added as a new CE cleared tool within QUIBIM Precision platform, which already received CE mark class IIa certification earlier in…
Our family keeps growing
We are proud to announce the incorporation of two new Quibimers in our growing team. Both excellent computer scientists, passionate about practising sport and named…
QUIBIM at the annual Outsourcing in Clinical Trials Europe 2019
We are very happy to share with you QUIBIM´s experience at the last Outsourcing in Clinical Trials Europe 2019 from 14th to 15th of May in…
QUIBIM uses AI to boost
breast cancer research
As the first ESMO Breast Cancer Congress unfolded 2-4 May in Berlin, Germany, QUIBIM CEO highlighted the role played by artificial intelligence (AI) in breast…
Comprehensive solutions will boost AI use in medical imaging
Integrating artificial intelligence (AI) into the radiologist’s workflow is still challenging, but all-inclusive solutions can help unfold algorithms’ power, QUIBIM CEO and founder Angel Alberich-Bayarri…